Literature DB >> 24313284

Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.

Claudine Mayer1, Yves L Janin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24313284     DOI： 10.1021/cr4003984

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  21 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 2.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.

Authors:  Xiaojie Huang; Junsong Guo; Qi Liu; Qiong Gu; Jun Xu; Huihao Zhou
Journal:  Medchemcomm       Date:  2018-07-04       Impact factor: 3.597

4.  High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea.

Authors:  Susanne Jacobsson; Daniel Golparian; Richard A Alm; Michael Huband; John Mueller; Jorgen Skov Jensen; Makoto Ohnishi; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 5.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

6.  Crystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutans.

Authors:  Jesse A Jones; Kirk E Hevener
Journal:  Biochem Biophys Res Commun       Date:  2019-06-14       Impact factor: 3.575

7.  Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.

Authors:  Sheo B Singh; David E Kaelin; Jin Wu; Lynn Miesel; Christopher M Tan; Peter T Meinke; David Olsen; Armando Lagrutta; Prudence Bradley; Jun Lu; Sangita Patel; Keith W Rickert; Robert F Smith; Stephen Soisson; Changqing Wei; Hideyuki Fukuda; Ryuta Kishii; Masaya Takei; Yasumichi Fukuda
Journal:  ACS Med Chem Lett       Date:  2014-03-12       Impact factor: 4.345

8.  High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.

Authors:  Magnus Unemo; Johan Ringlander; Catherine Wiggins; Hans Fredlund; Susanne Jacobsson; Michelle Cole
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

9.  Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.

Authors:  Shahul Hameed P; Anandkumar Raichurkar; Prashanti Madhavapeddi; Sreenivasaiah Menasinakai; Sreevalli Sharma; Parvinder Kaur; Radha Nandishaiah; Vijender Panduga; Jitendar Reddy; Vasan K Sambandamurthy; D Sriram
Journal:  ACS Med Chem Lett       Date:  2014-06-02       Impact factor: 4.345

10.  A simplified protocol for high-yield expression and purification of bacterial topoisomerase I.

Authors:  Jesse A Jones; Emily Price; Donovan Miller; Kirk E Hevener
Journal:  Protein Expr Purif       Date:  2016-04-23       Impact factor: 1.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.